Natalie S Marzec1, Mary T Bessesen2. 1. Division of Adult Infectious Diseases, University of Colorado Denver, Aurora, CO; Department of Veterans Affairs Eastern Colorado Healthcare System, Denver, CO. 2. Division of Adult Infectious Diseases, University of Colorado Denver, Aurora, CO; Department of Veterans Affairs Eastern Colorado Healthcare System, Denver, CO. Electronic address: Mary.Bessesen@ucdenver.edu.
Abstract
BACKGROUND: The risk of nosocomial methicillin-sensitive Staphylococcus aureus bacteremia in patients with nasal colonization on admission is 3-fold higher than in patients who are not colonized. Limited data on this question have been reported for methicillin-resistant S aureus (MRSA). METHODS: This is an observational cohort study of patients admitted to a tertiary care medical center from October 1, 2007-September 30, 2013, who underwent active screening for nasal colonization with MRSA. RESULTS: There were 29,371 patients who underwent screening for nasal MRSA colonization; 3,262 (11%) were colonized with MRSA. There were 32 cases of MRSA bacteremia among colonized patients, for an incidence of 1%. Thirteen cases of bacteremia occurred in non-MRSA-colonized patients, for an incidence of 0.05%. The odds of developing MRSA bacteremia for patients who were nasally colonized with MRSA compared with those who were not colonized were 19.89. There was no difference between colonized and noncolonized subjects with bacteremia in all-cause mortality at 30 days or 1 year. CONCLUSIONS: In a setting with active screening for MRSA, the risk of MRSA bacteremia is 19.89-fold higher among colonized than noncolonized patients. Published by Elsevier Inc.
BACKGROUND: The risk of nosocomial methicillin-sensitive Staphylococcus aureus bacteremia in patients with nasal colonization on admission is 3-fold higher than in patients who are not colonized. Limited data on this question have been reported for methicillin-resistant S aureus (MRSA). METHODS: This is an observational cohort study of patients admitted to a tertiary care medical center from October 1, 2007-September 30, 2013, who underwent active screening for nasal colonization with MRSA. RESULTS: There were 29,371 patients who underwent screening for nasal MRSA colonization; 3,262 (11%) were colonized with MRSA. There were 32 cases of MRSA bacteremia among colonized patients, for an incidence of 1%. Thirteen cases of bacteremia occurred in non-MRSA-colonized patients, for an incidence of 0.05%. The odds of developing MRSA bacteremia for patients who were nasally colonized with MRSA compared with those who were not colonized were 19.89. There was no difference between colonized and noncolonized subjects with bacteremia in all-cause mortality at 30 days or 1 year. CONCLUSIONS: In a setting with active screening for MRSA, the risk of MRSA bacteremia is 19.89-fold higher among colonized than noncolonized patients. Published by Elsevier Inc.
Entities:
Keywords:
Staphylococcus aureus; bacteremia; carrier state; methicillin-resistant S aureus
Authors: Joy Uwemedimo; Deirdre Fitzgerald-Hughes; Peter Kinnevey; Anna Shore; David Coleman; Hilary Humphreys; Toney Thomas Poovelikunnel Journal: J Infect Prev Date: 2020-06-13
Authors: Lloyd S Miller; Vance G Fowler; Sanjay K Shukla; Warren E Rose; Richard A Proctor Journal: FEMS Microbiol Rev Date: 2020-01-01 Impact factor: 16.408
Authors: Ahmad Mukifza Harun; Huzaika Awang; Nor Farid Mohd Noor; Nur Mohamad Makhatar; Mohamad Ezany Yusoff; Nor Dalila Nor Affandi; Mohammad Khursheed Alam Journal: Biomed Res Int Date: 2021-11-23 Impact factor: 3.411